+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2018 Pharmaceuticals Research Review

  • ID: 4753666
  • Report
  • Region: Global
  • 129 Pages
  • BCC Research
1 of 3
Report Scope

The pharmaceutical sector is undergoing expansions driven by the unmet need in several disease areas. Launch of novel therapies, that included cell and gene therapy with an increase in access to medicines is also driving the growth of the pharmaceutical market. The approval of second CAR T-cell therapy tisagenlecleucel (Kymriah) in 2018 signifies the dramatic progress in the field. Pharmaceutical sector witnessed uncertainties due to the US presidential elections, and weak economic growth in 2017 which have now settled down leading to steady growth in the sector.

Pharmaceutical industry is continuing the pursuit of drug discovery, and development for meeting the worldwide unmet need in the area of oncology, and orphan diseases with an unprecedented rigor. Pharma sector ratifies this trend with a rich cancer pipeline, availability of clinical and real-world data and an increase in associated investments. Pharma industry would surge owing to mergers and acquisitions that bolster company’s portfolio, drive innovation, and unlocks synergies. The merger announcement of Bristol-Myers Squibb and Celgene would create a new biopharmaceutical leader with deep and broad pipeline to deliver high-value innovation medicines.
Note: Product cover images may vary from those shown
2 of 3

Chapter 1 Foreword

  • Foreword

Chapter 2 Cognition and Memory Enhancement Drugs: Technologies and Global Markets

  • Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources and Methodology
  • Intended Audience
  • Geographic Breakdown
  • Analyst’s Credentials
  • Custom Research
  • Related Reports
  • Summary and Highlights
  • Market Definition
  • Ethics and Cognition and Memory-enhancing Drugs
  • Treatments Available for Dementia
  • Cholinesterase Inhibitors
  • Memantine
  • Nondrug Treatments for Dementia
  • Availability of Dementia Treatments
  • Side Effects of Cognition and Memory-enhancing Drugs
  • Benefits and Side Effects of Consuming Cognition Drugs
  • Technology Trends
  • Recent Studies Highlighting Potential of Cognition Drugs in Chess
  • Market Breakdown by Application
  • Alzheimer’s Disease
  • Patents Overview
  • Patent Analysis
  • Patents Filed in Asia-Pacific

Chapter 3 Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global Markets

  • Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Intended Audience
  • Scope of the Study
  • Methodology
  • Information Sources
  • Geographic Breakdown
  • Analyst's Credentials
  • Related Reports
  • Summary and Highlights
  • Cancer
  • Recent Advances in Technology
  • Invasive Power
  • Circulating Tumor Cells
  • Phenotypic Characteristics
  • CTC Clusters
  • CTC Detection
  • Circulating Tumor Cells - Potential Uses
  • Circulating Tumor Cell Market - A New Approach
  • Current Status of the Market
  • Patents Overview
  • Key Patents

Chapter 4 Global Viral Vector Manufacturing Markets and Technologies Through 2022

  • Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Methodology
  • Geographic Breakdown
  • Analyst’s Credentials
  • Related Research Reports
  • Summary and Highlights
  • Market and Technology Background
  • Market Potential
  • WHO
  • Market Segmentation
  • Segmentation by Type
  • Overview

Chapter 5 Checkpoint Inhibitors: Global Markets

  • Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst’s Credentials
  • Related Reports
  • Summary and Highlights
  • Immuno-Oncology
  • Costimulatory Immune Checkpoint Targets
  • Inhibitory Immune Checkpoint Targets
  • Immunometabolic Modulatory Targets
  • Unmet Medical Needs
  • New Biomarkers to Stratify Patients
  • Relapse/Refractory Patients
  • PD-1/PD-L1 Agents Introduction
  • Market Forecasts

Chapter 6 Lysosomal Disease Treatments: Technologies and Global Markets

  • Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst’s Credentials
  • Related Reports
  • Summary and Highlights
  • Definition
  • Lysosomes
  • Lysosomal Storage Diseases
  • Most Common LSDs
  • Market Breakdown by Region
  • North America

Chapter 7 High-Throughput Screening: Technologies and Global Markets

  • Introduction
  • Study Goals and Objectives
  • Intended Audience
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Related Reports
  • Summary and Highlights
  • Evolution of High-Throughput Screening
  • Miniaturization of Assays for High-Throughput Screening
  • Optimization of High-Throughput Screening
  • Conclusion
  • Artificial Intelligence and Automated Devices in HTS
  • Mass Spectrometry (MS)
  • Imaging Mass Spectrometry
  • MALDI Mass Spectrometry
  • Secondary Ion Mass Spectrometer
  • Mass Spectrometry Instruments
  • Patent Analysis

Chapter 8 Neuroprotective Agents: Therapeutic Applications and Global Markets

  • Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Related Reports
  • Summary and Highlights
  • Neuroprotection
  • Why Are Neuroprotective Therapies Needed?
  • Neuroprotective Strategies
  • Market Breakdown by Therapeutic Indication
  • Neuroprotective Agents for Cerebrovascular Disease

List of Tables
Table 1: Global Market for Cognition and Memory-enhancing Drugs, by Region, Through 2022
Table 2: Key Trends in Global Cognition Drugs and Memory Enhancers
Table 3: Causes of Dementia and Associated Characteristics
Table 4: Global Market for Cognition and Memory-enhancing Drugs, by Application, Through 2022
Table 5: Patent Review of Cognition Drugs Market, 2013-2016
Table 6: Patent Review of Cognition Drugs Market, by Region, 2013-2016
Table 7: Global Circulating Tumor Cell Technology Market, by Cancer Type, Through 2022
Table 8: Key Success Factors of CTCs
Table 9: CTCs - Differentiating Features
Table 10: Estimated Pricing
Table 11: CellSearch Kit
Table 12: Global Circulating Tumor Cell Testing Market, by Country/Region, Through 2022
Table 13: Circulating Tumor Cell Assay Characteristics
Table 14: CTC Selected Patents
Table 15: Global Viral Vector Vaccine Manufacturing Market, by Type, Through 2022
Table 16: Characteristics of Potential Viral Vaccine Vectors
Table 17: Advantages and Disadvantages of Major Viral Vectors
Table 18: Global Viral Vector Vaccine Manufacturing Market, by Disease Segment, Through 2022
Table 19: Global Market for Checkpoint Inhibitors, by Drug Class, Through 2023
Table 20: Comparison of PD-L1-PD-L2 ligands
Table 21: Global Market for Anti-PD-1/PD-L1 Therapies, by Product, Through 2023
Table 22: Global Market for Lysosomal Storage Diseases Treatment, by Type, Through 2023
Table 23: Types of Lysosomal Storage Diseases
Table 24: Most Common LSDs
Table 25: North American Market for Lysosomal Storage Diseases Treatment, by Type, Through 2023
Table 26: Global Market for High-Throughput Screening, by Region, Through 2023
Table 27: Automated Microplate Handling Systems in High-Throughput Screening
Table 28: Global Market for Mass Spectrometry, by Region, Through 2023
Table 29: Total Number of Patents in High-Throughput Screening, 2016-2018
Table 30: Number of Patents on High-Throughput Screening, by Key Players, 2016-2017
Table 31: Global Market for Neuroprotective Agents, by Region, Through 2022
Table 32: Global Market for Neuroprotective Agents, by Therapeutic Indication, Through 2022
Table 33: Global Market for Neuroprotective Agents Used in Treating Cerebrovascular Disease, Through 2022

List of Figures
Figure 1: Global Market for Cognition and Memory-enhancing Drugs, by Region, 2016-2022
Figure 2: Global Circulating Tumor Cell Technology Market, by Cancer Type, 2012-2022
Figure 3: Global Circulating Tumor Cell Testing Market, by Country/Region, 2012-2022
Figure 4: Global Viral Vector Vaccine Manufacturing Market, by Type, 2016-2022
Figure 5: Vaccine Research Cycle
Figure 6: WHO Mandatory Steps for Vaccine Approval
Figure 7: Life Cycle of Virus in Cells
Figure 8: Key Properties of Viral Vector
Figure 9: Global Market for Checkpoint Inhibitors, by Drug Class, 2017-2023
Figure 10: Potential Targets for Checkpoint Inhibition in Clinical Evaluation
Figure 11: Global Market for Anti-PD-1/PD-L1 Therapies, by Product, 2017-2023
Figure 12: Global Market for Lysosomal Storage Diseases Treatment, by Type, 2017-2023
Figure 13: Global Market for High-Throughput Screening, by Region, 2017-2023
Figure 14: High-Throughput Screening Well Specification
Figure 15: Triangle of High-Throughput Screening
Figure 16: Components of Mass Spectrometer
Figure 17: Advantages of MALDI-TOF instruments
Figure 18: Global Market for Neuroprotective Agents, by Region, 2016-2022
Figure 19: Global Market for Neuroprotective Agents, by Therapeutic Indication, 2016-2022
Figure 20: Global Market for Neuroprotective Agents Used in Treating Cerebrovascular Disease, 2016-2022

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

Adroll
adroll